LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Nexalin Technology (NASDAQ: NXL)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ NXL Nexalin Technology
Shelton Carolyn Hamby / officer: Sr. VP - Quality - Regulatory
09/12/2025
Buy
$2.95
20,000
$59K
110,620
NASDAQ NXL Nexalin Technology
Owens David / director, officer: Chief Medical Officer
09/12/2025
Buy
$0.96
100,000
$96K
1.48M
NASDAQ NXL Nexalin Technology
Owens David / director, officer: Chief Medical Officer
09/12/2025
Buy
$0.96
203,125
$195K
1.38M
NASDAQ NXL Nexalin Technology
Elson Marilyn / 10 percent owner
09/10/2025
Sell
$4.15
23,150
$96K
112,850